ProBioGen co-develops new Freedom ExpiCHO-S cell line development kit
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of US $112 million in the US
Subscribe To Our Newsletter & Stay Updated